Data for: Marrow Hypocellularity, but Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients with Morphologic Residual Disease
Published: 09-02-2018| Version 1 | DOI: 10.17632/fczyvxth6z.1
Contributors:
Description
Data set of outcomes based on day 14 bone marrow assessment.